NEW YORK, September 18, 2017 /PRNewswire/ --
According to a recent report by New Frontier Data, the Viridian Cannabis Stock Index gained 236.1% in 2016 and outperforming such mainstream indexes as the Russell 2000 (up 19.5%), the Dow Jones Industrial Average (up 13.4%), the S&P 500 (up 9.5%), and the Nasdaq composite (up 7.5%). New Frontier Data also reported that legal cannabis sales in California alone are projected to reach $2.8 billion in 2017 and $6.6 billion by 2025, with a compound annual growth rate of 12% over the next eight years. Medical cannabis products are now legal in 29 states and Washington DC. Chineseinvestors.com, Inc. (OTC: CIIX), Medical Marijuana, Inc. (OTC: MJNA), Terra Tech Corp. (OTC: TRTC), CV Sciences, Inc. (OTC: CVSI), Cannabis Sativa, Inc. (OTC: CBDS)
A significant portion of the total legal cannabis market is the CBD market. Cannabidiol (CBD) is the part of the cannabis plant that is usually used for medical purposes, and is a natural component of industrial cannabis or hemp. Growth of the medical cannabis market is expected to accelerate as the products become more popular treatments for various medical applications such as chronic pain, post-traumatic stress disorder (PTSD), sleep disorders, anxiety, nerve pain and others. Bethany Gomez, the Director of Research at Brightfield Group said, "Essentially everyone is trying to do hemp, but only a handful are doing it well. It's seen as easy because it can be sold online but, with restrictions on traditional marketing, it is very difficult to connect with your core consumer and even communicate why they need your product," Forbes reported.
Chineseinvestors.com, Inc. (OTCQB: CIIX) announced earlier today that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., has completed the filing process with the China Food & Drug Administration ("CFDA") for its first line of non-industrial hemp-infused skin care products. The Company expects to launch the CBD Magic Hemp Series skin care line in October positioning CBD Biotechnology as a leader in what it believes to be an untapped segment of China's skin care industry.
The CBD Magic Hemp Series launch will include three (3) products: - The CBDBIO TECH Brightening and Refreshing Moisturizer - intended to balance the skin's moisture, while forming a protective, moisturizing layer; - The CBDBIO TECH Perfecting Shield Primer - intended to even skin tone, while covering fine lines and minimizing the look of pores; and - The CBDBIO TECH Peptide Collagen Solution - intended to moisturize and firm the skin, while smoothing fine lines, and reducing signs of aging.
The CBD Magic Hemp Series line is different from other skin care lines currently available in China because the products are infused with hemp extract, otherwise known as cannabidiol or CBD. CBD, a powerful antioxidant and anti-inflammatory agent, has been widely used in skin care products in western countries for some time. Although a catalogue provided by the CFDA entitled "Catalogue of Cosmetics Raw Materials in Use (2015)" includes Cannabis Sativa Leaf Extract, CBD Biotechnology is not aware of any other Chinese skin care manufacturers that have entered this emerging market, setting the stage for CBD Biotechnology to proudly take the lead with its innovative product line.
"I am very pleased to announce the upcoming launch of CBD Biotechnology's hemp-infused skin care line, the CBD Magic Hemp Series," says Summer Yun, CEO of CBD Biotechnology Co., Ltd. "We have not only completed the filing process with CFDA, but we have also contracted with a large processing factory in Shanghai, China, with over 14-years of experience in cosmetics production."
"China has one of the world's largest consumer markets for skin care products. Retail sales of skincare products and make-up products in China reached 169.1 billion yuan and 28.3 billion yuan respectively in 2016, with year-over-year growth of 5% and 12% respectively. Skin care is expected to reach 223.3 billion yuan in 2021 with growth driven by rising awareness of skin health and consumption upgrading Chinese consumers. As one of the first hemp infused skin care brands in China, we are confident that CBD Biotechnology will lead Chinese market, with potential for global expansion."
Medical Marijuana, Inc. (OTC: MJNA) on August 21 announced that the State of Mexico's government has purchased the company's Real Scientific Hemp Oil-X™ CBD hemp oil products from its subsidiary HempMeds Mexico® to treat 11 of its citizens suffering from varying indications including Refractory Epilepsy and Lennox Gastaut-Syndrome. This is the first time a government in Mexico has purchased CBD products for its citizens. HempMeds® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexicoplans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products.
Terra Tech Corp. (OTCQX: TRTC) announced last week that it has expanded its retail operations into Southern California through the acquisition of 100% of the assets of Tech Center Drive Management LLC. Under the terms of transaction, Terra Tech has the right to operate the dispensary, and to consolidate 100% of Tech Center Drive's financial results into the Company's financial results. Derek Peterson, CEO of Terra Tech, commented, "The Reserve has a reputation for first-rate, patient-focused customer service and is expected to generate steady cash flow to the Company. This represents another milestone in our M&A strategy to rapidly expand our retail operations without needing to invest significant time or funds into building dispensaries."
CV Sciences, Inc. (OTCQB: CVSI) announced on September 5th that its industry dominating brand of finished products, PlusCBD Oil™ will be exhibiting at Natural Products Expo East on September 14-16, in Baltimore, Maryland. PlusCBD Oil™ is currently being sold in approximately 1300 health food stores and continues to grow its shelf presence in various retail outlets across the country. "It's evident that hemp-derived CBD products are doing better and growing faster than almost every other category in the supplement industry, and it's been a long time since we've seen a supplement trend truly demonstrate demand in such an immense fashion," commented Stuart Tomc, VP of Human Nutrition and spokesperson for CV Sciences.
Cannabis Sativa, Inc. (OTCQB: CBDS) announced on September 6th that the Company has granted an exclusive license to the Sowilde Management Group, Inc. to allow Sowilde to produce products under the Company's "hi" and "White Rabbit" brands. White Rabbit offers fast acting low dose cannabis oral sprays and low dose cannabis mints. Both the spray and the mints are formulated as CBD, THC and CBD/THC blends. Dosage ranges include 2.5mg, 5mg and 10mg tablets and sprays with 1:1 and 20:1 variations of each. "Sowilde Management Group understands the market uniqueness of these products for the rapidly growing industry. We believe Sowilde is a great fit to exploit our brands and intellectual property in the State of California," said President David Tobias.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.